Cresco Labs Statistics
Total Valuation
Cresco Labs has a market cap or net worth of CAD 361.97 million. The enterprise value is 959.66 million.
Market Cap | 361.97M |
Enterprise Value | 959.66M |
Important Dates
The last earnings date was Friday, March 14, 2025.
Earnings Date | Mar 14, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Cresco Labs has 351.43 million shares outstanding. The number of shares has increased by 6.69% in one year.
Current Share Class | n/a |
Shares Outstanding | 351.43M |
Shares Change (YoY) | +6.69% |
Shares Change (QoQ) | +0.17% |
Owned by Insiders (%) | 68.33% |
Owned by Institutions (%) | 5.71% |
Float | 111.28M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.35 |
PB Ratio | 0.53 |
P/TBV Ratio | n/a |
P/FCF Ratio | 2.23 |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.33, with an EV/FCF ratio of 5.90.
EV / Earnings | -8.96 |
EV / Sales | 0.93 |
EV / EBITDA | 3.33 |
EV / EBIT | 5.96 |
EV / FCF | 5.90 |
Financial Position
The company has a current ratio of 3.12, with a Debt / Equity ratio of 1.65.
Current Ratio | 3.12 |
Quick Ratio | 2.00 |
Debt / Equity | 1.65 |
Debt / EBITDA | 3.20 |
Debt / FCF | 5.66 |
Interest Coverage | 1.90 |
Financial Efficiency
Return on equity (ROE) is -14.82% and return on invested capital (ROIC) is 6.54%.
Return on Equity (ROE) | -14.82% |
Return on Assets (ROA) | 5.16% |
Return on Invested Capital (ROIC) | 6.54% |
Return on Capital Employed (ROCE) | 8.88% |
Revenue Per Employee | 355,125 |
Profits Per Employee | -36,933 |
Employee Count | 2,900 |
Asset Turnover | 0.53 |
Inventory Turnover | 3.77 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -62.95% in the last 52 weeks. The beta is 2.02, so Cresco Labs's price volatility has been higher than the market average.
Beta (5Y) | 2.02 |
52-Week Price Change | -62.95% |
50-Day Moving Average | 1.21 |
200-Day Moving Average | 1.80 |
Relative Strength Index (RSI) | 42.99 |
Average Volume (20 Days) | 154,030 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Cresco Labs had revenue of CAD 1.03 billion and -107.10 million in losses. Loss per share was -0.31.
Revenue | 1.03B |
Gross Profit | 512.04M |
Operating Income | 161.08M |
Pretax Income | -15.27M |
Net Income | -107.10M |
EBITDA | 246.11M |
EBIT | 161.08M |
Loss Per Share | -0.31 |
Balance Sheet
The company has 197.93 million in cash and 920.34 million in debt, giving a net cash position of -722.41 million or -2.06 per share.
Cash & Cash Equivalents | 197.93M |
Total Debt | 920.34M |
Net Cash | -722.41M |
Net Cash Per Share | -2.06 |
Equity (Book Value) | 558.52M |
Book Value Per Share | 1.96 |
Working Capital | 287.65M |
Cash Flow
In the last 12 months, operating cash flow was 190.62 million and capital expenditures -28.05 million, giving a free cash flow of 162.57 million.
Operating Cash Flow | 190.62M |
Capital Expenditures | -28.05M |
Free Cash Flow | 162.57M |
FCF Per Share | 0.46 |
Margins
Gross margin is 49.72%, with operating and profit margins of 15.64% and -10.40%.
Gross Margin | 49.72% |
Operating Margin | 15.64% |
Pretax Margin | -1.48% |
Profit Margin | -10.40% |
EBITDA Margin | 23.90% |
EBIT Margin | 15.64% |
FCF Margin | 15.79% |
Dividends & Yields
Cresco Labs does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -6.69% |
Shareholder Yield | -6.69% |
Earnings Yield | -29.59% |
FCF Yield | 44.91% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Cresco Labs has an Altman Z-Score of -0.05. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -0.05 |
Piotroski F-Score | n/a |